Hydroxy acids and derivatives
eMolecules 478922-47-3 | (3R,5S)-5-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride | MFCD09056830 | 1g
Ambeed | (S)-4-(tert-Butyl)-2-(6-(dicyclopentylmethyl)pyridin-2-yl)-45-dihydrooxazole | 100mg | 721601895 | A1519809 | | 354.538 | C23H34N2O
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
C[13C](O)=O | 100mg | 483413034](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502177357.JPG-250.jpg)
eMolecules (3R)-3-Hydroxybutyric Acid-1-13C | Toronto Research Chemicals |105.097 | C4H8O3C[C@@H](O)C[13C](O)=O | 100mg | 483413034
(3R)-3-Hydroxybutyric Acid-1-13C | Toronto Research Chemicals |105.097 | C4H8O3C[C@@H](O)C[13C](O)=O | 100mg | 483413034
Medchemexpress LLC 2-hydroxybutyric acid (α-hydroxybutyric acid) | 600-15-7 | 98.0% | 104.10 | 1 G
2-Hydroxybutyric acid (α-Hydroxybutyric acid) is an endogenous metabolite, converted from 2-Aminobutyric acid. It serves as a potential biomarker for type 2 diabetes and preeclampsia and has shown the ability to prevent acetaminophen (AP)-induced liver injury. This compound is synthesized as a coproduct of insulin resistance, contributing to insulin signaling impairment and mitochondrial overload.
- Enhances cell viabilities and decreases AP-induced toxicities in BRL3A, AML12, and mice primary hepatocytes.
- Prevents AP-induced liver injury in C57 mice.
- Normalizes gene expressions related to inflammation response, oxidative stress, cell proliferation, and DNA damage.
eMolecules 167216-30-0 | AstaTech | TERT-BUTYL (3-HYDROXYBUTYL)CARBAMATE | 0.1g | 718059951 | I11078 | 95 | MFCD04974277 | 189.255 | C9H19NO3
Ambeed | 44-(Ethane-12-diyl)bis(morpholine-26-dione) | 5g | 532081368 | A181777 | 23911-25-3 | MFCD00074963 | 256.214 | C10H12N2O6
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC Varenicline tartrate | 375815-87-5 | MFCD08460603 | >=98.0% | 361.3 g/mol | C13H13N3·C4H6O6 | 10 MG
Varenicline tartrate is the tartrate salt of varenicline, a partial agonist of α4β2 nicotinic acetylcholine receptors. Supplied as a research/analytical standard in solid form, it is intended for laboratory use such as pharmacology, method development, and analytical testing; not for human consumption.
- High purity suitable for research and analytical applications (≥98% by HPLC).
- Off-white to yellow crystalline solid.
- Available in small vials, including a 10 MG pack size.
- Provided as a defined chemical salt for reproducible assay results.
- CAS number 375815-87-5 for unambiguous identification.
Medchemexpress LLC Butanoic acid,3-hydroxy- | 300-85-6 | 99.8% | 104.10 | 1 G
3-Hydroxybutyric acid is an endogenous metabolite that is elevated in type I diabetes. It can modulate the properties of membrane lipids, interacting with lipid monolayers and altering phase behavior at clinical concentrations.
- Endogenous metabolite
- Interacts with lipid monolayers and alters phase behavior at clinical concentrations
- Diminishes the interfacial viscosity of DPPC Monolayers
- Appearance: <33°C Solid, >34°C Liquid
- Color: Off-white to light yellow
- Initial source: Microorganisms
Selleck Chemical LLC 2-Hydroxybutyric acid
2-Hydroxybutyric acid ( -hydroxybutyrate) is converted from 2-Aminobutyric acid It is produced in mammalian tissues (principally hepatic) that catabolize L-threonine or synthesize glutathione
Medchemexpress LLC Metoprolol tartrate | 56392-17-7 | 99.98% | 342.41 | 50 MG
Metoprolol tartrate is a selective β1-adrenoceptor antagonist that is orally active. It has demonstrated anti-inflammatory, antitumor, and anti-angiogenic properties. This compound is intended for research use only and exhibits dose and time-dependent cytotoxic effects on U937 and MOLT-4 cells in vitro, and reduces proinflammatory cytokines and atherosclerosis in ApoE-/- Mice in vivo.
- Selective β1-adrenoceptor antagonist.
- Orally active.
- Multi-faceted properties: anti-inflammatory, antitumor, and anti-angiogenic effects.
- Exhibits cytotoxic effects on U937 and MOLT-4 cells in vitro.
- Reduces proinflammatory cytokines and atherosclerosis in ApoE-/- Mice.
- Exhibits anti-inflammation and anti-virus effects in a murine model with coxsackievirus B3-induced viral myocarditis.
- Inhibits myocardial apoptosis in coronary microembolization (CME) rats.
Bachem DL-b-Phenyllactic acid
DL-b-Phenyllactic acid, 828-01-3, C9H10O3, Mr 166.18, 25g. (RS)-2-Hydroxy-3-phenyl-propionic acid. The racemate and both enantiomers of PLA show antifungal activity.
eMolecules 6280-99-5 | Dl-malic acid di-n-butyl ester | MFCD00059251 | 25g
Combi-Blocks | Dl-malic acid di-n-butyl ester | 25g | 457919894 | QE-0382 | 95.000 | 6280-99-5 | MFCD00059251 | 246.303 | C12H22O5
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
AdipoGen (S)-3-Hydroxybutyric acid (25 mg)
Chemical. CAS: 6168-83-8. Formula: C4H8O3. MW: 104.1. Physiologically insignificant stereoisomer of (R)-3-Hydroxybutyric acid, a key metabolite of the ketolytic pathway. Anticonvulsant. Endogenous inhibitor of histone deacetylases (HDACs) 1, 3 and 4. Ligand of free fatty acid receptor 3 (FFAR3; GPR41) and hydroxycarboxylic acid receptor 2 (HCAR2; GPR109B). NLRP3 inflammasome inhibitor. Prevents K+-efflux and reduces ASC oligomerization and speck formation.
[C@@H](O)C(=O)OC(C)(C)C | 1g | 267204233](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502189749.JPG-250.jpg)
eMolecules 117384-45-9 | (+)-Di-tert-butyl L-tartrate | Combi-Blocks | MFCD00192000 | 262.302 | C12H22O6 | 95.000 | CC(C)(C)OC(=O)[C@H](O)[C@@H](O)C(=O)OC(C)(C)C | 1g | 267204233
(+)-Di-tert-butyl L-tartrate | Combi-Blocks | 117384-45-9 | MFCD00192000 | 262.302 | C12H22O6 | 95.000 | CC(C)(C)OC(=O)[C@H](O)[C@@H](O)C(=O)OC(C)(C)C | 1g | 267204233
Apexbio Technology LLC PYRANTEL-TARTRATE-500MG
Pyrantel tartrate (CAS No 33401-94-4) is a compound classified under the category of antiparasitic agents primarily used in veterinary medicine It originates from tetrahydropyrimidines and functions as a cholinergic agonist targeting nicotinic acetylcholine receptors at the neuromuscular junction of nematodes This mechanism causes spastic paralysis in parasites facilitating their expulsion In vitro activity of pyrantel tartrate is generally observed in the nanomolar to low micromolar range depending on the organism It is commonly applied in studies involving cell models of nematode infections and is used in animal studies to evaluate its efficacy as an anthelmintic The compound is also utilized in drug screening efforts to discover new treatments for parasitic infections Experimental concentrations typically depend on the specific research design
Apexbio Technology LLC PYRANTEL-TARTRATE-100MG
Pyrantel tartrate (CAS No 33401-94-4) is a compound classified under the category of antiparasitic agents primarily used in veterinary medicine It originates from tetrahydropyrimidines and functions as a cholinergic agonist targeting nicotinic acetylcholine receptors at the neuromuscular junction of nematodes This mechanism causes spastic paralysis in parasites facilitating their expulsion In vitro activity of pyrantel tartrate is generally observed in the nanomolar to low micromolar range depending on the organism It is commonly applied in studies involving cell models of nematode infections and is used in animal studies to evaluate its efficacy as an anthelmintic The compound is also utilized in drug screening efforts to discover new treatments for parasitic infections Experimental concentrations typically depend on the specific research design